) has been revised to $28.82 / share. This is an increase of 10.24% from the prior estimate of $26.14 dated March 25, 2026. The price target is an average of many targets provided by analysts. The ...
Jade Biosciences (JBIO) has announced the pricing of a public offering of 10M shares of its common stock, priced at $15.00 per share, expected to raise gross proceeds of $150M from this offering. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results